http://seekingalpha.com/article/293435-6-deeply-undervalued-biotech-companies?source=yahoo
Recent VNDA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:07:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:16:52 PM
- Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results • PR Newswire (US) • 11/06/2024 09:02:00 PM
- Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024 • PR Newswire (US) • 10/30/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:00:01 PM
- Ericsson Shares Surge 7% on Strong Earnings, Nvidia Drops 2%, Google Invests in Nuclear Power for AI • IH Market News • 10/15/2024 09:46:33 AM
- Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd. • PR Newswire (US) • 10/14/2024 02:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 09:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 12:10:32 PM
- FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis • PR Newswire (US) • 09/19/2024 11:00:00 AM
- Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference • PR Newswire (US) • 09/11/2024 09:00:00 PM
- Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference • PR Newswire (US) • 09/04/2024 09:13:00 PM
- Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference • PR Newswire (US) • 08/29/2024 08:30:00 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 08/08/2024 11:47:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:29:01 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:01:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:05:32 PM
- Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 07/31/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 09:24:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/29/2024 09:21:33 PM
- Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024 • PR Newswire (US) • 07/26/2024 01:19:00 PM
- Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex • PR Newswire (US) • 07/01/2024 12:01:00 PM
- Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders • PR Newswire (US) • 06/20/2024 12:48:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:38:04 PM
- Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak • PR Newswire (US) • 06/13/2024 02:02:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM